InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.11
(
-0.46%
)
Bitcoin
55,361.52
(
-0.87%
)
Post# of 252505
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

BTH

Send PM Follow Ignore
Followers 16
Posts 4145
Boards Moderated 1
Alias Born 06/11/2010

BTH

Re: None

Saturday, 01/05/2013 12:18:26 PM

Saturday, January 05, 2013 12:18:26 PM

Post# of 252505
$TGTX Anyone want to discuss their ublituximab CD20? I believe this is derived from goats (spun-out from former Genzyme company):

Since then, GTC has worked on an undisclosed new use for ATryn. It licensed a compound called ublituximab to TG Therapeutics Inc. as a possible treatment for cancer and autoimmune diseases.



http://www.telegram.com/article/20120325/NEWS/103259992/1002/RSS01&source=rss
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up